ArticlePediatric research2026
Commentary: moving towards improved awareness and diagnosis of pediatric sarcopenia.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marcelo Flores-Opazo, et al., in the manuscript titled "Advancing toward the diagnosis of sarcopenia in the pediatric population", have brought to light the difficulties in diagnosing pediatric sarcopenia and have proposed muscle mass-strength-functionality triad in creating a comprehensive definition of pediatric sarcopenia. Good quality studies on pediatric sarcopenia are lacking due to paucity of age and sex specific normative data for skeletal muscle mass and strength, especially in young children and infants. To enable an accurate diagnosis of sarcopenia in children, systematic data on growth, neurocognitive developmental status, and factors affecting physiological growth and development in various pediatric age groups are urgently warranted. As an initial step, promotion of physical literacy accompanied by regular activity would promote improved muscle strength, leading to the acquisition of improved fundamental movement skills contributing to normal growth and development. Consensus is essential in methodological approaches for sarcopenia diagnosis, body composition and skeletal muscle mass measurements, and age-appropriate muscle function tests in children. Early detection and management of sarcopenia in children would help reduce the healthcare burden and improve outcomes.
Identifiers
42026209What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.